NPM1 and anaplastic large cell lymphoma: ALK is a receptor tyrosine kinase (RTK) first identified in anaplastic large cell lymphoma patients, where ALK translocations led to an aberrant fusion protein with nucleophosmin (NPM) (discussed in more detail below, Morris et al., 1994).